花生四烯酸市场规模 - 按形式（固体和溶剂）按来源（植物和动物）按应用（婴儿配方奶粉和补充剂）和预测，2024 - 2032 年

由于消费者对必需脂肪酸在维持整体健康和福祉方面的重要性的认识不断提高，预计 2024 年至 2032 年花生四烯酸市场规模的CAGR将超过 3.9%。

根据疾病预防控制中心和美国农业部的数据，十分之九的美国人患有钾缺乏症。随着全球消费者健康意识的不断增强，对含有花生四烯酸的膳食补充剂的需求激增，特别是在膳食缺乏症普遍存在的地区。此外，婴儿配方奶粉和功能性食品中越来越多地采用花生四烯酸，也有助于市场成长。

整个花生四烯酸市场根据形式、应用和地区进行分类。

由于其在药品、化妆品和动物饲料等各个行业的广泛应用，预计到 2032 年，溶剂型细分市场将在市场上产生大量收入。溶剂形式的花生四烯酸用作生产抗发炎药物、护肤配方和动物饲料添加剂的关键成分。其多功能性和有效性有利于产品的采用。

由于越来越多的消费者将花生四烯酸补充剂纳入其日常饮食方案，预计到 2032 年，补充剂应用领域将大幅成长。随着饮食偏好转向功能性食品和营养补充剂，製造商正在利用这一趋势，提供各种针对各种健康益处的富含花生四烯酸的产品。此外，生活方式相关疾病的日益普及和人口老化正在推动对旨在促进心血管健康、认知功能和整体健康的补充剂的需求。

在完善的製药和食品行业以及支持花生四烯酸在膳食补充剂和婴儿配方奶粉中使用的有利监管框架的推动下，到 2032 年，欧洲花生四烯酸行业规模将显着扩大。此外，旨在探索花生四烯酸治疗潜力的研发活动的投资不断增加，进一步推动了该地区的市场成长。随着消费者意识的不断增强和饮食模式的不断变化，欧洲对于花生四烯酸製造商和供应商来说仍然是一个利润丰厚的市场。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：花生四烯酸产业洞察

• 产业生态系统分析
• 技术与创新格局
• 监管环境
• 产业影响力
  • 成长动力
  • 产业陷阱与挑战
• 成长潜力分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按表格，2018-2032 年

• 主要趋势
• 坚硬的
• 溶剂

第 6 章：市场估计与预测：依来源划分，2018-2032 年

• 主要趋势
• 植物
• 动物

第 7 章：市场估计与预测：按应用2018-2032

• 主要趋势
• 婴幼儿配方奶粉
• 补充
• 其他的

第 8 章：市场估计与预测：按地区，2018-2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 马来西亚
  • 印尼
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• MEA
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第 9 章：公司简介

• BASF SE
• Beijing Gingko Group (BGG)
• Cargill, Incorporated
• Cayman Chemical
• Croda International Plc
• DSM Nutritional Products
• Enzymotec (Acquired by Frutarom)
• Jarrow Formulas
• Kingdomway Nutrition Inc.
• Lallemand Health Solutions
• Lipoid GmbH
• Martek Biosciences Corporation (now part of DSM)
• Suntory Holdings Limited
• Xiamen Kingdomway Group Company
• Zhejiang Medicine Co., Ltd.

Arachidonic acid market size is anticipated to record more than 3.9% CAGR from 2024 to 2032 owing to the rising consumer awareness regarding the importance of essential fatty acids in maintaining overall health and well-being.

As per the CDC and the USDA, 9 out of 10 Americans have a potassium deficiency. With growing health consciousness among consumers worldwide, there has been a surge in demand for dietary supplements containing arachidonic acid, particularly in regions where dietary deficiencies are prevalent. Additionally, the increasing adoption of arachidonic acid in infant formula and functional food products contributes to market growth.

The overall arachidonic acid market is classified based on form, application, and region.

The solvent form segment is predicted to generate massive revenue in the market by 2032 owing to its wide-ranging applications across various industries such as pharmaceuticals, cosmetics, and animal feed. Arachidonic acid in solvent form is used as a key ingredient in the production of anti-inflammatory drugs, skin care formulations, and animal feed additives. Its versatility and effectiveness are favoring the product adoption.

The supplement application segment is expected to witness substantial growth through 2032 owing to an increasing number of consumers incorporating arachidonic acid supplements into their daily dietary regimes. As dietary preferences shift towards functional foods and nutritional supplements, manufacturers are capitalizing on this trend by offering a diverse range of arachidonic acid-enriched products targeting various health benefits. Moreover, the growing prevalence of lifestyle-related disorders and the aging population are driving the demand for supplements aimed at promoting cardiovascular health, cognitive function, and overall wellness.

Europe arachidonic acid industry size will expand significantly through 2032, propelled by the p well-established pharmaceutical and food sectors, coupled with favorable regulatory frameworks supporting the use of arachidonic acid in dietary supplements and infant formula. Additionally, increasing investments in R&D activities aimed at exploring the therapeutic potential of arachidonic acid are further driving market growth in the region. With growing consumer awareness and evolving dietary patterns, Europ remains a lucrative market for arachidonic acid manufacturers and suppliers.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Market 360 degree synopsis

Chapter 3 Arachidonic Acid Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Technology & innovation landscape
• 3.3 Regulatory landscape
• 3.4 Industry impact forces
  • 3.4.1 Growth drivers
  • 3.4.2 Industry pitfalls & challenges
• 3.5 Growth potential analysis
• 3.6 Porter's analysis
  • 3.6.1 Supplier power
  • 3.6.2 Buyer power
  • 3.6.3 Threat of new entrants
  • 3.6.4 Threat of substitutes
  • 3.6.5 Industry rivalry
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Company market share analysis
• 4.2 Competitive positioning matrix
• 4.3 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Form, 2018-2032 (USD Million, Kilo Tons)

• 5.1 Key trends
• 5.2 Solid
• 5.3 Solvent

Chapter 6 Market Estimates & Forecast, By Source, 2018-2032 (USD Million, Kilo Tons)

• 6.1 Key trends
• 6.2 Plant
• 6.3 Animal

Chapter 7 Market Estimates & Forecast, By Application 2018-2032 (USD Million, Kilo Tons)

• 7.1 Key trends
• 7.2 Infant formula
• 7.3 Supplement
• 7.4 Others

Chapter 8 Market Estimates & Forecast, By Region, 2018-2032 (USD Million, Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 UK
  • 8.3.2 Germany
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Russia
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 South Korea
  • 8.4.5 Australia
  • 8.4.6 Malaysia
  • 8.4.7 Indonesia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 MEA
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 South Africa

Chapter 9 Company Profiles

• 9.1 BASF SE
• 9.2 Beijing Gingko Group (BGG)
• 9.3 Cargill, Incorporated
• 9.4 Cayman Chemical
• 9.5 Croda International Plc
• 9.6 DSM Nutritional Products
• 9.7 Enzymotec (Acquired by Frutarom)
• 9.8 Jarrow Formulas
• 9.9 Kingdomway Nutrition Inc.
• 9.10 Lallemand Health Solutions
• 9.11 Lipoid GmbH
• 9.12 Martek Biosciences Corporation (now part of DSM)
• 9.13 Suntory Holdings Limited
• 9.14 Xiamen Kingdomway Group Company
• 9.15 Zhejiang Medicine Co., Ltd.